Amundi - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 360 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.02 and the average weighting 0.2%.

Quarter-by-quarter ownership
Amundi ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,968,005
+7.2%
65,974
+46.4%
0.00%0.0%
Q2 2023$1,835,084
+188.3%
45,077
+153.5%
0.00%
Q1 2023$636,453
+0.2%
17,783
+5.0%
0.00%
Q4 2022$635,269
-55.5%
16,936
-27.7%
0.00%
-100.0%
Q3 2022$1,427,000
+110.8%
23,426
+120.9%
0.00%0.0%
Q2 2022$677,000
+74.5%
10,607
+80.2%
0.00%
Q1 2022$388,000
+103.1%
5,887
+175.5%
0.00%
Q4 2021$191,000
-23.0%
2,137
+15.8%
0.00%
Q3 2021$248,0001,8460.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Atlas Venture Associates IX, LLC 1,615,321$23,697,00041.29%
ARK Investment Management 8,741,432$128,237,0003.23%
Nikko Asset Management Americas, Inc. 7,178,520$105,309,0001.66%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$1,635,0000.86%
Elmwood Wealth Management, Inc. 64,204$942,0000.82%
361 CAPITAL LLC 94,772$1,390,0000.38%
Artal Group S.A. 199,700$2,930,0000.11%
StoneX Group Inc. 14,982$220,0000.09%
Sumitomo Mitsui Trust Holdings, Inc. 7,178,520$105,309,0000.08%
PDT Partners, LLC 85,517$1,255,0000.08%
View complete list of INTELLIA THERAPEUTICS INC shareholders